Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harald Morr

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Pneumologie (Stuttgart, Germany)|December 17, 2009
[Announcement -- Doctoral prize of the German Lung Foundation]Harald Morr
Medizinische Klinik (Munich, Germany : 1983)|April 12, 2006
[Therapeutic goals and outcome measurements in COPD patients]Harald Morr
Pneumologie (Stuttgart, Germany)|October 18, 2006
[COPD and sleep]Harald Morr, Gratiana Steinkamp
Cancer Letters|April 15, 2003
Tumor M2-pyruvate kinase in the follow-up of inoperable lung cancer patients: a pilot studyJoachim Schneider, Kathleen Neu, Hans-Georg Velcovsky, et al.
Anticancer Research|June 25, 2003
Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseasesJoachim Schneider, Monika Philipp, Hans-Georg Velcovsky, et al.
International Journal of Clinical Oncology|July 12, 2002
Fuzzy logic-based tumor-marker profiles improved sensitivity in the diagnosis of lung cancerJoachim Schneider, Norman Bitterlich, Hans-Georg Velcovsky, et al.
Anticancer Research|June 25, 2003
Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patientsJoachim Schneider, Gregor Peltri, Norman Bitterlich, et al.
Medizinische Klinik (Munich, Germany : 1983)|August 17, 2004
[The German Respiratory Society's Guideline for the Diagnosis and Treatment of Patients with Acute and Chronic Cough]Peter Kardos, Ulrich Cegla, Adrian Gillissen, et al.
BMC Cancer|February 27, 2008
Do genetic factors protect for early onset lung cancer? A case control study before the age of 50 yearsAlbert Rosenberger, Thomas Illig, Katrin Korb, et al.
BMC Cancer|April 25, 2008
Early onset lung cancer, cigarette smoking and the SNP309 of the murine double minute-2 (MDM2) geneKirstin Mittelstrass, Wiebke Sauter, Albert Rosenberger, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Pneumologie (Stuttgart, Germany)|December 17, 2009
[Announcement -- Doctoral prize of the German Lung Foundation]Harald Morr
Medizinische Klinik (Munich, Germany : 1983)|April 12, 2006
[Therapeutic goals and outcome measurements in COPD patients]Harald Morr
Pneumologie (Stuttgart, Germany)|October 18, 2006
[COPD and sleep]Harald Morr, Gratiana Steinkamp
Cancer Letters|April 15, 2003
Tumor M2-pyruvate kinase in the follow-up of inoperable lung cancer patients: a pilot studyJoachim Schneider, Kathleen Neu, Hans-Georg Velcovsky, et al.
Anticancer Research|June 25, 2003
Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseasesJoachim Schneider, Monika Philipp, Hans-Georg Velcovsky, et al.
International Journal of Clinical Oncology|July 12, 2002
Fuzzy logic-based tumor-marker profiles improved sensitivity in the diagnosis of lung cancerJoachim Schneider, Norman Bitterlich, Hans-Georg Velcovsky, et al.
Anticancer Research|June 25, 2003
Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patientsJoachim Schneider, Gregor Peltri, Norman Bitterlich, et al.
Medizinische Klinik (Munich, Germany : 1983)|August 17, 2004
[The German Respiratory Society's Guideline for the Diagnosis and Treatment of Patients with Acute and Chronic Cough]Peter Kardos, Ulrich Cegla, Adrian Gillissen, et al.
BMC Cancer|February 27, 2008
Do genetic factors protect for early onset lung cancer? A case control study before the age of 50 yearsAlbert Rosenberger, Thomas Illig, Katrin Korb, et al.
BMC Cancer|April 25, 2008
Early onset lung cancer, cigarette smoking and the SNP309 of the murine double minute-2 (MDM2) geneKirstin Mittelstrass, Wiebke Sauter, Albert Rosenberger, et al.
Pageof 1